medigraphic.com
ISSN 1561-3119 (Electronic)

2012, Number 2

<< Back

Rev Cubana Pediatr 2012; 84 (2)

Successful treatment of parotid hemangioma by using propranolol

Moredo RE, Pastrana FF

Language: Spanish
References: 9
Page:
PDF size: 185.68 Kb.


ABSTRACT

Infantile hemangiomas are the most common benign vascular tumors in childhood that mostly emerge in preterm patients, affect head and neck in 80% of cases and cause serious life-threatening complications for some patients. The parotid hemangioma is a clinical form of presentation that may be seen in a prolonged proliferative period with slow regression. This is the clinical case of a patient diagnosed with parotid hemangioma of superficial and deep component. He was treated with propranolol, showed excellent response to treatment, and complete clinical and imaging regression of tumor in a 10-week period.


REFERENCES

  1. Escutia Muñoz B, Febrer Bosch I. Tratamiento médico de los hemangiomas. Piel. 2002;17(3):139-44.

  2. Sánchez-Carpintero I, Hortanilla B. Hemangiomas infantiles y malformaciones vasculares. Claves diagnósticas y tratamiento. Barcelona: Ed. ESMONpharma. 2008. p. 15-63.

  3. Moredo E, de la Peña T, Matos V L, Monzón M, Cárdenas MM. Presentación de 3 casos de hemangiomas infantiles tratados con propranolol. Rev Cubana Pediatr [serie en internet]. 2011 [citado 20 de octubre de 2011];83(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312011000300012&lng=es&nrm=iso&tlng=es

  4. Tincopa R, Alemán N, Membrides P, Suárez O. Eficacia clínica y seguridad de los corticoides sistémicos a altas dosis en hemangiomas. Lima. Dermatol.peru. 2005;15(3):196-205.

  5. Bennet ML, Fleischer AB, Chamlin SL, Fieden JJ. Oral corticosteroid use is effective for cutaneous hemangioma. An evidence-based evaluation. Arch Dermatol. 2001;147:1208-13.

  6. Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J. Propranolol for several infantile hemangiomas: follow-up report. Pediatric. 2009;124:423-31.

  7. Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Beliveau R. Propranolol adrenergic blockade inhibist human brain endothelial cells tubulogenesis and matrix metalloproteinace-9 secretion. Pharmacol Res. 2009;60:438-45.

  8. Ballona R. Beta-bloqueadores y hemangiomas: de lo fortuito a lo accidental. Dermatología Pediátrica Latinoamericana. 2010;8(1):46-9.

  9. Cordisco RM. Propranolol en el tratamiento de los hemangiomas. Dermatología Pediátrica Latinoamericana. 2008;6(2):95-6.




2020     |     www.medigraphic.com